Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position

Bioorg Med Chem. 2013 Nov 1;21(21):6665-73. doi: 10.1016/j.bmc.2013.08.016. Epub 2013 Aug 12.

Abstract

We have reported potent peptidic and non-peptidic BACE1 inhibitors with a hydroxymethylcarbonyl (HMC) isostere as a substrate transition-state mimic. However, our potent inhibitors possess a tetrazole ring at the P1' position. It is desirable that central nervous system (CNS) drugs do not possess an acidic moiety. In this study, we synthesized non-acidic BACE1 inhibitors with heterocyclic derivatives at the P1' position. KMI-1764 (27) exhibited potent inhibitory activity (IC50=27nM). Interestingly, these non-acidic inhibitors tended to follow the quantitative structure-activity relationship (QSAR) equation and interacted with BACE1-Arg235 in the binding model.

Keywords: Alzheimer’s disease; Hydroxymethylcarbonyl isostere; Non-acidic inhibitor; Quantitative structure–activity relationship; β-Secretase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid Precursor Protein Secretases / antagonists & inhibitors*
  • Amyloid Precursor Protein Secretases / genetics
  • Amyloid Precursor Protein Secretases / metabolism
  • Aspartic Acid Endopeptidases / antagonists & inhibitors*
  • Aspartic Acid Endopeptidases / genetics
  • Aspartic Acid Endopeptidases / metabolism
  • Benzamides / chemical synthesis
  • Benzamides / chemistry*
  • Benzamides / metabolism
  • Heterocyclic Compounds / chemical synthesis
  • Heterocyclic Compounds / chemistry*
  • Heterocyclic Compounds / metabolism
  • Humans
  • Hydrogen Bonding
  • Protease Inhibitors / chemical synthesis
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / metabolism
  • Protein Binding
  • Quantitative Structure-Activity Relationship
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Thiadiazoles / chemical synthesis
  • Thiadiazoles / chemistry*
  • Thiadiazoles / metabolism

Substances

  • Benzamides
  • Heterocyclic Compounds
  • N1-(4-(5-bromo-1,3,4-thiadiazol-2-ylamino)-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-5-(N-methylmethanesulfonamido)-N3-(1-phenylethyl)isophthalamide
  • Protease Inhibitors
  • Recombinant Proteins
  • Thiadiazoles
  • Amyloid Precursor Protein Secretases
  • Aspartic Acid Endopeptidases
  • BACE1 protein, human